13D Filing: Birchview Capital and Yield10 Bioscience Inc. (YTEN)

Page 12 of 12

Page 12 of 12 – SEC Filing

SIGNATURE

After reasonable
inquiry and to the best of the undersigned’s knowledge and belief, the undersigned hereby certifies that the information
set forth in this statement is true, complete and correct.

Dated: December 29, 2017

BIRCHVIEW FUND, LLC
By:

/s/ Richard McCormick

Name:   Richard McCormick
Title: CFO
BIRCHVIEW CAPITAL, LP
By:

/s/ Matthew Strobeck

Name: Matthew Strobeck
Title: Managing Partner
BIRCHVIEW CAPITAL GP, LLC
By:

/s/ Matthew Strobeck

Name: Matthew Strobeck
Title: Partner
BIRCHVIEW PARTNERS, LLC
By:

/s/ Matthew Strobeck

Name: Matthew Strobeck
Title: Principal
By:

/s/ Matthew Strobeck

Name: Matthew Strobeck
(Page 12 of 12 Pages)

Follow Yield10 Bioscience Inc. (NASDAQ:YTEN)

Page 12 of 12